In early 2015 the Australian Consumer and Competition Commission (ACCC) authorized a new Code of Conduct for Medicines Australia
(representing the larger drug companies in Australia but not generic makers). This 18th Code Edition now includes making public all payments to doctors who speak at drug company events, payments for work on company advisory boards, and the monetary equivalent of gifts from companies to doctors for overseas and local travel, accommodation, conference registration fees and other forms of hospitality.
This move to greater transparency started back in 2009 and culminated this year with the adoption of many of the elements of the US Physician Payment Sunshine Act.
Not included in the ACCC authorized Code is payments for food and drink below $120 per person. Payments associated with industry funded research trials are also not included. The payments will be published for individual doctors on a six-monthly basis on drug company websites accessible to the public.
To read the article by Dr Philip Morris